Harnessing Diacylglycerol-Terminated Cationic Oligomers for Next-Generation Antibacterial Therapeutics
This study reports the synthesis and evaluation of diacylglycerol-terminated cationic oligomers (CLOs) that exhibit potent, selective, and biocompatible antibacterial activity against priority pathogens, particularly MRSA and *A. baumannii*, with efficacy and spectrum tunable by polymer length and cationic functionality.